Carolyn S Menendez MD FACS (She/Her)
Breast
Director, clinical cancer genetics National Oncology Program (VA), Assistant professor, Duke Surgical oncology; Breast Surgeon
Join to View Full Profile
4101 Macon Pond RoadRaleigh, NC 27607
Phone+1 919-854-6900
Dr. Menendez is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- I am a breast surgeon with Duke Cancer Institute. I also have additional training in cancer genetics and work with the hereditary cancer clinic and molecular tumor board at Duke. As of September 2022 I am also the director of clinical cancer genetics for the National Oncology Program (VA).
Education & Training
City of hopeCertification, Clinical Cancer Genetics, 2011 - 2012
University of California (San Francisco)/FresnoResidency, Surgery, 1999 - 2004
Eastern Virginia Medical SchoolInternship, Transitional Year, 1998 - 1999- Eastern Virginia Medical SchoolClass of 1998
Certifications & Licensure
CA State Medical License 2000 - Present
NC State Medical License 2008 - 2026
WA State Medical License 2025 - 2026
SC State Medical License 2013 - 2019
ME State Medical License Active through 2009
American Board of Surgery Surgery
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification PowerChart, Cerner Healthe, Cerner Patient Portal, HealthSentry and P2 Sentinel, Cerner Corporation, 2013-2014, 2017
- CMS Meaningful Use Stage 1 Certification Cerner Patient Portal and Powerchart, Cerner Corporation, 2013-2014, 2017
- CMS Meaningful Use Stage 1 Certification MEDSEEK Empower, SymphonyCare, LLC, 2013-2014, 2017
Publications & Presentations
PubMed
- Pathogenic germline variants in a racially diverse real-world cohort of prostate cancer patients.Taylor B Crawford, Maliha Tayeb, Emanuel Barrett, Tara Al-Saleem, Pranavi Kondam
Medrxiv. 2025-08-15 - 1 citationsHigh risk surveillance MRI may not be necessary in BRCA1/2 mutation carriers over 70 years old.Astrid Botty van den Bruele, Yi Ren, Samantha M Thomas, Koumani W Ntowe, Laura H Rosenberger
Breast Cancer Research and Treatment. 2025-06-01 - 2 citationsMainstreaming improved adoption of germline testing for Veterans Affairs patients with metastatic prostate cancer without exacerbating disparities.Maren T Scheuner, Katherine J Hoggatt, Paloma Sales, Barbara Lerner, Eva Ferino
Genetics in Medicine. 2025-05-01
Committees
- Committee member, American Society of Breast Surgeons, Genetics Committee 2018 - 2019
Professional Memberships
- Member
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
